Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Κατάταξη σε μετοχές
#3638
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Τιμή μετοχής
$3.69
Κεφαλαιοποίηση
$4.66B
Αλλαγή (1 ημέρα)
1.72%
Αλλαγή (1 έτος)
-52.26%
Χώρα
CN
Εμπόριο Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Κατηγορία
Healthcare
EPS για Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
EPS στις June 2026 TTM: $-0.04
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., το τρέχον EPS της εταιρείας (TTM) είναι $-0.04. Στο τέλος του 2023, η εταιρεία είχε EPS $0.14, μείωση σε σύγκριση με το EPS του 2022 που ήταν $0.55.
Ιστορικό EPS της Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. από 2013 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $-0.04 | -535.00% |
| 2024 | $0.01 | -92.14% |
| 2023 | $0.14 | -74.54% |
| 2022 | $0.55 | 112.95% |
| 2021 | $0.26 | 195.53% |
| 2020 | $0.09 | 219.78% |
| 2019 | $0.03 | -30.53% |
| 2018 | $0.04 | 70.13% |
| 2017 | $0.02 | 14.36% |
| 2016 | $0.02 | 9.19% |
| 2015 | $0.02 | -4.64% |
| 2014 | $0.02 | 45.86% |
| 2013 | $0.01 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| $17.32 | -39,916.09% |
US
|
|
| $-7.98 | 18,244.83% |
US
|
|
| $-5.29 | 12,060.92% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -63,870.11% |
NL
|
